A Systematic Review of Flurbiprofen 8.75 mg Dose and Risk of Haemorrhagic Events

• Main Authors: Sandeep Dhanda (Author), Alison Evans (Author), Debabrata Roy (Author), Vicki Osborne (Author), Adam Townsley (Author), Graça Coutinho (Author), Anuradha Kulasekaran (Author), Saad Shakir (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Oral non-steroidal anti-inflammatory drugs (NSAIDs) are known to be associated with an increased risk of bleeding. The NSAID, flurbiprofen, in the form of 8.75 mg lozenge or oromucosal spray is indicated for the symptomatic relief of sore throat. Despite the low dose as compared to alternative flurb...